Fifth Lane Capital, Lp
Source: SEC Form 13F · as of Mar 2026Fifth Lane Capital, Lp holds 12 biotech & pharma companies tracked by BioSniper, totaling $10.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$10.2M
| Company | Shares | Value |
|---|---|---|
| ACLXArcellx, Inc. | 31,044 | $3.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 7,000 | $1.9M |
| ABVXAbivax SA | 15,858 | $1.8M |
| NKTRNEKTAR THERAPEUTICS | 12,000 | $863K |
| RNAAtrium Therapeutics Inc. | 35,999 | $481K |
| TERNTerns Pharmaceuticals, Inc. | 8,000 | $422K |
| RLMDRELMADA THERAPEUTICS, INC. | 45,000 | $313K |
| APLSApellis Pharmaceuticals, Inc. | 7,500 | $302K |
| CRNXCrinetics Pharmaceuticals, Inc. | 7,161 | $260K |
| SABSSAB BIOTHERAPEUTICS, INC. | 46,500 | $178K |
| CNTBConnect Biopharma Holdings Ltd | 45,000 | $118K |
| IKTInhibikase Therapeutics, Inc. | 24,896 | $42K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.